Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
127.70
-0.87 (-0.68%)
At close: Jul 9, 2026, 4:00 PM EDT
127.20
-0.50 (-0.39%)
Pre-market: Jul 10, 2026, 4:52 AM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $7.79 billion as of July 10, 2026. Its market cap has increased by 207.59% in one year.
Market Cap
7.79B
Enterprise Value
7.72B
1-Year Change
207.59%
Ranking
Category
Stock Price
$127.70
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $7.79B, an increase of 2,519.99%. That is a compound annual growth rate of 59.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.79B | 90.75% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 9.04B |
| Protagonist Therapeutics | 8.89B |
| Crinetics Pharmaceuticals | 8.81B |
| Vaxcyte | 8.66B |
| Immunovant | 8.35B |
| TG Therapeutics | 8.24B |
| Spyre Therapeutics | 8.12B |
| Rhythm Pharmaceuticals | 7.87B |